Goldman Sachs Group Inc Clear Point Neuro, Inc. Transaction History
Goldman Sachs Group Inc
- $613 Billion
- Q4 2024
A detailed history of Goldman Sachs Group Inc transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 130,048 shares of CLPT stock, worth $2.17 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
130,048
Previous 29,150
346.13%
Holding current value
$2.17 Million
Previous $326,000
513.5%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding CLPT
# of Institutions
93Shares Held
7.57MCall Options Held
390KPut Options Held
28.7K-
Vanguard Group Inc Valley Forge, PA1.25MShares$20.9 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA509KShares$8.51 Million0.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA409KShares$6.84 Million1.22% of portfolio
-
Black Rock Inc. New York, NY366KShares$6.13 Million0.0% of portfolio
-
Brown Advisory Inc333KShares$5.57 Million0.01% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $409M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...